Time in Range
9
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Real Time Continuous Glucose Monitoring System in T2DM With Pregnacy
Efficacy of the Use of Real-time Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes and Stage 3 and 4 Chronic Kidney Disease.
Influence of the Use of Specific Nutritional Formulas on Time in Range in Patients With Type 2 Diabetes
Evaluating an Insulin Pump for Time in Range (TIR) in Patients with Type 1 Diabetes
Feasibility of DPP-4 Inhibitor Therapy on Advanced Hybrid Closed Loop System
Insulin Dose Calculation Software in Insulin Therapy
Comparison of Safety and Efficacy of Needle-Free Injector and Insulin Pen in Patients With T2DM
Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM
The Use of Faster Acting Aspart in Type 1 Diabetes Patients